Enzyme action could be target for diabetes, heart disease treatments
CINCINNATI—Cardiac researchers at the University of Cincinnati (UC) have found a new cellular pathway that could help in developing therapeutic treatments for obesity-related disorders, like diabetes and heart disease.
This research is being presented at the American Heart Association's Scientific Session in Chicago Nov. 16.
Tapan Chatterjee, PhD, and researchers in the division of cardiovascular diseases found that action by the enzyme histone deacetylase 9 (HDAC9) can lead to obesity-induced body fat dysfunction and that HDAC9-regulated pathways could be targets for ...





